Pharmacy
Only about one-third of adults have received the booster aimed at the Omicron variant, which remains highly transmissible.
High drug prices create affordability challenges for patients and the healthcare system, one of two reports found.
NACDS also wants to establish a Medicare reimbursement pathway for pharmacy care services including vaccinations and therapeutics.
The pitch to potential users is an integrated solution from one company that offers a more holistic approach to care.
HIMSS22
Bob Katter, president of First Databank, explains how the FDB Vela electronic prescribing network can improve contracting and access for clinicians and pharmacies.
The BA.4 and BA.5 lineages of the omicron variant are currently causing most cases of COVID-19 and are predicted to circulate this fall.
BCBS is accusing Teva of offering coupons to prevent consumers from switching to a generic, lower-cost version of Copaxone.
Health officials are trying to move all vaccines to intradermal dosing as in a strategy to stretch supply.
Part D's programmatic structure may lead to plan sponsors preferring higher-cost versions of hepatitis C drugs, OIG finds.
This will increase the total number of doses available for use by up to fivefold, according to the agency.